PURPOSE: Diabetes mellitus, a metabolic disorder caused by an absolute or relative deficiency of insulin, is a debilitating and costly disease with multiple serious complications. Lower urinary tract complications are among the most common complications of diabetes mellitus. The most common, bothersome lower urinary tract complication of diabetes mellitus is diabetic cystopathy or diabetic bladder dysfunction. We reviewed the current translational knowledge of diabetic bladder dysfunction. MATERIALS AND METHODS: We performed a search of the English literature through PubMed. The key words used were diabetes and bladder dysfunction or cystopathy. Our data and perspective are provided for consideration of the future direction of research. RESULTS: Despite traditional recognition of diabetic bladder dysfunction as a voiding problem characterized by poor emptying and overflow incontinence, recent clinical and experimental evidence indicate storage problems such as urgency and urge incontinence in diabetes mellitus cases. Recent experimental evidence from studies of diabetic bladder dysfunction in small animal models of diabetes mellitus show a temporal effect on diabetic bladder dysfunction. Early phase diabetes mellitus causes compensated bladder function and the late phase causes decompensated bladder function. The temporal theory could plausibly provide the scientific road map to correlate clinical and experimental findings, and identify the role of mechanisms such as polyuria, hyperglycemia, oxidative stress, autonomic neuropathy and decompensation of the bladder contractile apparatus in the creation of clinical and experimental manifestations of diabetic bladder dysfunction. CONCLUSIONS: Diabetic bladder dysfunction includes time dependent manifestations of storage and emptying problems. Identifying mechanistic pathways would lead to the identification of therapeutic intervention.
PURPOSE:Diabetes mellitus, a metabolic disorder caused by an absolute or relative deficiency of insulin, is a debilitating and costly disease with multiple serious complications. Lower urinary tract complications are among the most common complications of diabetes mellitus. The most common, bothersome lower urinary tract complication of diabetes mellitus is diabetic cystopathy or diabetic bladder dysfunction. We reviewed the current translational knowledge of diabetic bladder dysfunction. MATERIALS AND METHODS: We performed a search of the English literature through PubMed. The key words used were diabetes and bladder dysfunction or cystopathy. Our data and perspective are provided for consideration of the future direction of research. RESULTS: Despite traditional recognition of diabetic bladder dysfunction as a voiding problem characterized by poor emptying and overflow incontinence, recent clinical and experimental evidence indicate storage problems such as urgency and urge incontinence in diabetes mellitus cases. Recent experimental evidence from studies of diabetic bladder dysfunction in small animal models of diabetes mellitus show a temporal effect on diabetic bladder dysfunction. Early phase diabetes mellitus causes compensated bladder function and the late phase causes decompensated bladder function. The temporal theory could plausibly provide the scientific road map to correlate clinical and experimental findings, and identify the role of mechanisms such as polyuria, hyperglycemia, oxidative stress, autonomic neuropathy and decompensation of the bladder contractile apparatus in the creation of clinical and experimental manifestations of diabetic bladder dysfunction. CONCLUSIONS:Diabetic bladder dysfunction includes time dependent manifestations of storage and emptying problems. Identifying mechanistic pathways would lead to the identification of therapeutic intervention.
Authors: Arun K Changolkar; Joseph A Hypolite; Michael Disanto; Peter J Oates; Alan J Wein; Samuel Chacko Journal: J Urol Date: 2005-01 Impact factor: 7.450
Authors: Dan Ziegler; Alexander Ametov; Alexey Barinov; Peter J Dyck; Irina Gurieva; Phillip A Low; Ullrich Munzel; Nikolai Yakhno; Itamar Raz; Maria Novosadova; Joachim Maus; Rustem Samigullin Journal: Diabetes Care Date: 2006-11 Impact factor: 19.112
Authors: S C Apfel; S Schwartz; B T Adornato; R Freeman; V Biton; M Rendell; A Vinik; M Giuliani; J C Stevens; R Barbano; P J Dyck Journal: JAMA Date: 2000-11-01 Impact factor: 56.272
Authors: S Ida; R Kaneko; H Nagata; Y Noguchi; Y Araki; M Nakai; S Ito; K Imataka; K Murata Journal: J Nutr Health Aging Date: 2019 Impact factor: 4.075
Authors: James M Hotaling; Aruna V Sarma; Darshan P Patel; Barbara H Braffett; Patricia A Cleary; Eva Feldman; William H Herman; Catherine L Martin; Alan M Jacobson; Hunter Wessells; Rodica Pop-Busui Journal: Diabetes Care Date: 2016-06-28 Impact factor: 19.112
Authors: Paul C Dolber; Huixia Jin; Rashid Nassar; Thomas M Coffman; Susan B Gurley; Matthew O Fraser Journal: Neurourol Urodyn Date: 2015-01 Impact factor: 2.696
Authors: Wu WenBo; Zhang Fei; Du YiHeng; Wang Wei; Yan TingMang; Zhou WenHao; Liu QianRu; Liu HaiTao Journal: Neurochem Res Date: 2017-09-26 Impact factor: 3.996
Authors: Karel Dewulf; Nitya Abraham; Laura E Lamb; Tomas L Griebling; Naoki Yoshimura; Pradeep Tyagi; Andrew Veerecke; Sarah N Bartolone; Bernadette M M Zwaans; Dirk De Ridder; Ananias Diokno; Michael B Chancellor Journal: Int Urol Nephrol Date: 2017-02-23 Impact factor: 2.370